TARGETED DELIVERY STRATEGIES

Theramir has developed a targeted delivery platform using exosomes and other nanoparticles engineered from stem cells, which can selectively target tumor sites and deliver their therapeutic payload directly to cancer cells. These targeted delivery vehicles can be loaded with specific miRNAs that can regulate multiple oncoproteins, potentially allowing the inhibition of multiple cancer pathways with a single approach. Thus, our approach offers significant advantages in terms of tumor selectivity and efficacy compared to current treatments and can potentially provide a new avenue to successfully treat a wide range of cancers.